FR940706-2-00055 FR940706-2-00037 FEDERAL TRADE COMMISSION [File No. 941 0019] The Dow Chemical Company, et al.; Proposed Consent Agreement With Analysis To Aid Public Comment AGENCY: Federal Trade Commission. ACTION: Proposed Consent Agreement. SUMMARY: In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would require, among other things, Marion Merrell Dow to license its dicyclomine formulations and production technology to a third party, and to contract manufacture dicyclomine for the third party while that party awaits the Food and Drug Administration approval to sell its own dicyclomine. The consent agreement also would prohibit future acquisition of any dicyclomine manufacturing, production or distribution capabilities without prior Commission approval. DATES: Comments must be received on or before September 6, 1994. ADDRESSES: Comments should be directed to: FTC/Office of the Secretary, Room 159, 6th St. and Pa. Ave., NW., Washington, DC 20580. FOR FURTHER INFORMATION CONTACT: Ann Malester or Claudia Higgins, FTC/S&hyph;2224, Washington, DC 20580. (202) 326&hyph;2682. SUPPLEMENTARY INFORMATION: Pursuant to Section 6(f) of the Federal Trade Commission Act, 38 Stat. 721, 15 U.S.C. 46 and Section 2.34 of the Commission's Rules of Practice (16 CFR 2.34), notice is hereby given that the following consent agreement containing a consent order to cease and desist, having been filed with and accepted, subject to final approval, by the Commission, has been placed on the public record for a period of sixty (60) days. Public comment is invited. Such comments or views will be considered by the Commission and will be available for inspection and copying at its principal office in accordance with Section 4.9(b)(6)(ii) of the Commission's Rules of Practice (16 CFR 4.9(b)(6)(ii)).
